Progressive help in prostate

Prostate cancer is the third-highest cause of cancer death in men after lung and bowel cancers.

Each year, more than 4000 men are diagnosed with prostate cancer, and more than 700 die from the disease.
Now the Prostate Cancer Foundation is advocating for Government to take the first steps towards a comprehensive early detection programme for the disease. Significant advances in technology, and improved diagnostic methods, mean that previous risks have been reduced. The latest research says a comprehensive early detection programme may halve mortality from the disease.
Earlier this month leading clinicians and cancer researchers attended the Prostate Cancer Foundation national conference in Auckland, with the theme “New Horizons in Prostate Cancer Care”.

In addition to debating the need for an early detection programme, conference topics included:

The latest science behind the role of diet and nutrition in slowing the progression of prostate cancer.
The latest position from the urological professional body on the role of the PSA blood test and how we should be looking to deploy it in the fight against prostate cancer.
New approaches to radiotherapy with the potential to fundamentally change the patient experience.
The vital role that new information and data plays in improving outcomes for patients, and what it can tell us about how we are performing as a nation in serving men affected by a prostate cancer diagnosis